Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Cure AS
AS
Active
Org 922537674
Kalfarveien 37, 5022
Bergen
Grafisk og visuell kommunikasjonsdesign
·
NACE 74102
Est. 2019 · 7 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Grafisk og visuell kommunikasjonsdesign
/
Cure AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
6M
5M
3M
2M
0M
2M
2019
5M
+150%
2020
3M
-40%
2021
0M
-100%
2022
EBITDA
NOK millions
1M
1M
0M
-1M
-1M
-1M
2019
1M
+200%
2020
-1M
-200%
2021
0M
+100%
2022
Income statement
NOK thousands
Item
2019
2020
2021
2022
Revenue
1 662
5 386
2 816
18
Staff expenses
−1 004
−1 432
−1 594
−16
EBITDA
−779
570
−1 331
−101
Depreciation & amort.
−0
−0
−0
−0
EBIT
−779
570
−1 331
−101
Net financials
0
−0
−1
−0
Profit before tax
−778
570
−1 332
−101
Tax
−0
−0
−0
−0
Net profit
−778
570
−1 332
−101
Balance sheet
NOK thousands
Item
2019
2020
2021
2022
Total assets
1 695
3 374
945
81
Equity
−678
−109
−1 440
−1 541
Long-term debt
0
0
0
0
Short-term debt
2 039
3 447
2 386
1 622
Total debt
2 039
3 447
2 386
1 622
Financial ratios
5-year trend
EBITDA margin
-566.5%
This company
15.8%
Market median
3685% below market
2019
2022
Equity ratio
-1910.2%
This company
38.2%
Market median
5101% below market
2019
2022
Return on equity
-10086500.0%
This company
18.4%
Market median
54818035% below market
2019
2022
Net profit margin
-567.3%
This company
8.1%
Market median
7104% below market
2019
2022
Asset turnover
0.22×
This company
1.12×
Market median
80% below market
2019
2022
Debt / equity
1.05×
This company
0.62×
Market median
69% above market
2019
2022
Annual reports & filings
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
More on Cure AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network